Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Mid Atlantic Retina, Philadelphia

Retina Vitreous Associates of Florida, St. Petersburg

Retina Consultants of Texas Woodlands, The Woodlands

Retina Consultants of Texas, Bellaire

Austin Clinical Research, Austin

Retina Research Institute of Texas, Abilene

Retinal Research Institute, LLC, Phoenix

Sierra Eye Associates, Reno

Retina Vitreous Associates Medical Group, Beverly Hills

Northern California Retina Vitreous Associates, Mountain View

Byers Eye Institute at Stanford, Palo Alto